Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites

British Journal of Dermatology

Volumn 164, Issue 6, 2011, Pages 1362-1368

  Tyrrell, J S ^a   Morton, C ^b   Campbell, S M ^a   Curnow, A ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b Stirling Royal Infirmary   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; PROTOPORPHYRIN;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BLEACHING; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AMINOLEVULINIC ACID; ANALYSIS OF VARIANCE; EXTREMITIES; FACIAL DERMATOSES; FEMALE; FLUORESCENCE; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PRECANCEROUS CONDITIONS; PROTOPORPHYRINS; SCALP DERMATOSES; SKIN NEOPLASMS;

EID: 79957624773     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10265.x     Document Type: Article

References (40)

1. Peng Q, Berg K, Moan J, et al. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 1997; 65: 235-51. (Pubitemid 27158805)
2. Henderson BW, Dougherty TJ,. How does photodynamic therapy work? Photochem Photobiol 1992; 55: 145-57.
3. Peng Q, Warloe T, Berg K, et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997; 79: 2282-308. (Pubitemid 27251011)
4. Annemans L, Caekelbergh K, Roelandts R, et al. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma. Eur J Dermatol 2008; 18: 539-46.
5. Basset-Seguin N, Ibbotson SH, Emtestam L, et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008; 18: 547-53.
6. Kaufmann R, Spelman L, Weightman W, et al. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol 2008; 158: 994-9. (Pubitemid 351521450)
7. Morton CA, Horn M, Leman J, et al. A placebo controlled European study comparing MAL-PDT with cryotherapy and 5-fluoracil in subjects with Bowen's disease. J Eur Acad Dermatol Venereol 2004; 18: 415 (Abstract).
8. Szeimies RM, Matheson RT, Davis SA, et al. Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study. Dermatol Surg 2009; 35: 586-92.
9. Tarstedt M, Rosdahl I, Berne B, et al. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol (Stockh) 2005; 85: 424-8. (Pubitemid 41345617)
10. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007; 56: 125-43. (Pubitemid 44969292)
11. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-67. (Pubitemid 34437765)
12. Morton CA, McKenna KE, Rhodes LE,. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008; 159: 1245-66.
13. Fink-Puches R, Hofer A, Smolle J, et al. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol B 1997; 41: 145-51. (Pubitemid 28010589)
14. Itoh Y, Ninomiya Y, Henta T, et al. Topical delta-aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses. J Dermatol 2000; 27: 513-18.
15. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol 1997; 133: 727-32. (Pubitemid 27263706)
16. Szeimies RM, Karrer S, Sauerwald A, et al. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 1996; 192: 246-51. (Pubitemid 26139209)
17. Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999; 41: 414-18. (Pubitemid 29418508)
18. Piaserico S, Belloni Fortina A, Rigotti P, et al. Topical photodynamic therapy of actinic keratosis in renal transplant recipients. Transplant Proc 2007; 39: 1847-50. (Pubitemid 47198804)
19. Tyrrell J, Campbell SM, Curnow A,. The validation of a non-invasive fluorescence imaging system to monitor clinical dermatological photodynamic therapy. Photodiagnosis Photodyn Ther 2010; 7: 86-97.
20. Smits T, Robles CA, van Erp PE, et al. Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. J Invest Dermatol 2005; 125: 833-9.
21. Tyrrell J, Campbell SM, Curnow A,. The utilization of a non-invasive fluorescence imaging system to follow clinical dermatological MAL-PDT. In: Photodynamic Therapy: Back to the Future (, Kessel DH, ed.). Proceedings of SPIE Vol. 7380. Bellingham, WA: SPIE, 2009; 73801P.
22. Szeimies RM, Ibbotson S, Murrell DF, et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008; 22: 1302-11.
23. Loh CS, Vernon D, MacRobert AJ, et al. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol B 1993; 20: 47-54. (Pubitemid 23257593)
24. Ascencio M, Collinet P, Farine MO, et al. Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy. Lasers Surg Med 2008; 40: 332-41. (Pubitemid 351920383)
25. Boere IA, Robinson DJ, De Bruijn HS, et al. Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy. Photochem Photobiol 2003; 78: 271-7.
26. Kruijt B, de Bruijn HS, van der Ploeg-van den Heuvel A, et al. Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy. Photochem Photobiol 2008; 84: 1515-27.
27. Robinson DJ, de Bruijn HS, van der Veen N, et al. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol 1998; 67: 140-9. (Pubitemid 128471972)
28. Tyrrell J, Campbell SM, Curnow A,. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome. Lasers Surg Med 2010; 42: 613-19.
29. Calzavara-Pinton PG, Venturini M, Sala R,. Photodynamic therapy: update 2006. Part 2: clinical results. J Eur Acad Dermatol Venereol 2007; 21: 439-51. (Pubitemid 46454894)
30. Sandby-Moller J, Poulsen T, Wulf HC,. Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits. Acta Derm Venereol (Stockh) 2003; 83: 410-13. (Pubitemid 37475779)
31. Smits T, Kleinpenning MM, Blokx WA, et al. Fluorescence diagnosis in keratinocytic intraepidermal neoplasias. J Am Acad Dermatol 2007; 57: 824-31. (Pubitemid 47553081)
32. Jun MS, Choi HS, Han I, et al. In vitro and ex vivo protoporphyrin IX expression induced by 5-aminolevulinic acid in human pilosebaceous unit. J Dermatol Sci 2005; 40: 68-70. (Pubitemid 41383902)
33. Thissen MR, Schroeter CA, Neumann HA,. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000; 142: 338-9. (Pubitemid 30117707)
34. Chang SC, MacRobert AJ, Porter JB, et al. The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study. J Photochem Photobiol B 1997; 38: 114-22. (Pubitemid 27277866)
35. Curnow A, Pye A,. Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors. J Environ Pathol Toxicol Oncol 2007; 26: 89-103. (Pubitemid 47295561)
36. Pye A, Campbell S, Curnow A,. Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma. J Cancer Res Clin Oncol 2008; 134: 841-9.
37. Juzeniene A, Juzenas P, Bronshtein I, et al. The influence of temperature on photodynamic cell killing in vitro with 5-aminolevulinic acid. J Photochem Photobiol B 2006; 84: 161-6.
38. Miyake M, Ishii M, Kawashima K, et al. siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines. Photochem Photobiol 2009; 85: 1020-7.
39. Merschbrock U, Hoffmann J, Caspary L, et al. Fast wavelength scanning reflectance spectrophotometer for noninvasive determination of hemoglobin oxygenation in human skin. Int J Microcirc Clin Exp 1994; 14: 274-81.
40. Caspary L, Thum J, Creutzig A, et al. Quantitative reflection spectrophotometry: spatial and temporal variation of Hb oxygenation in human skin. Int J Microcirc Clin Exp 1995; 15: 131-6.